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Abstract (353 words) 5 
Background 6 
Osteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have 7 
reported epidemiological associations suggesting that large body mass, long bone length and 8 
the genetics of certain breeds including the Rottweiler are associated with elevated 9 
osteosarcoma risk. However, these studies were often limited by selection bias and 10 
confounding factors, and have rarely offered insights into breed-associated protection for 11 
osteosarcoma. The current study includes 1756 appendicular and axial osteosarcoma cases 12 
presenting to VPG Histology (Bristol, UK) compared against a control population of 905,211 13 
dogs without osteosarcoma from primary care electronic patient records in the VetCompass™ 14 
dataset. 15 
 16 
Methods and Study Design 17 
Retrospective, case-control study. Multivariable logistic regression analysis explored 18 
associations between demographic risk factors (including breed, chondrodystrophy, age, 19 
sex/neuter status, skull-shape, and body mass) and osteosarcoma of all anatomical sites.  20 
 21 
Results 22 
We identified several breeds with increased and reduced odds of osteosarcoma. At highest 23 
risk were the Rottweiler and Great Dane, with >10 times the odds of osteosarcoma compared 24 
with crossbreds, and the Rhodesian Ridgeback; which has not featured in previous lists of at-25 
risk breeds for osteosarcoma, and had an odds ratio of 11.31 (95% confidence interval 7.37 - 26 
17.35). Breeds at lowest risk of osteosarcoma (protected breeds) included the Bichon Frise, 27 
the French Bulldog and the Cavalier King Charles Spaniel, all with odd ratios of less than 0.30 28 
 3 
compared with crossbreds. Body mass was strongly associated with osteosarcoma risk; dogs 1 
over 40kg exhibited osteosarcoma odds of 45.44 (95% confidence interval 33.74 - 61.20) 2 
compared with dogs less than 10kg. Chondrodystrophic breeds had an osteosarcoma odds 3 
ratio of 0.13 (95% confidence interval 0.11 - 0.16) compared with non-chondrodystrophic 4 
breeds.  5 
 6 
Conclusions 7 
This study provides evidence of strong breed-associated osteosarcoma risk and protection, 8 
suggesting a genetic basis for osteosarcoma pathogenesis. It highlights that breeds bred for 9 
long legs/large body mass are generally overrepresented amongst at-risk breeds, whilst those 10 
bred for short leg length/small body mass are generally protected. These findings could inform 11 
genetic studies to identify osteosarcoma risk alleles in canines and humans; as well as 12 
increasing awareness amongst vets and owners, resulting in improved breeding practices and 13 
clinical management of osteosarcoma in dogs. 14 
 15 
Plain English Summary 203 words 16 
Osteosarcoma is a painful and aggressive bone tumour in dogs that is known to be more 17 
common in certain breeds than others. The finding that bone-tumours are more common in 18 
certain breeds tells us that a dog’s genetics play a role in bone tumour development. There is 19 
much research aimed at identifying exactly which genetic differences cause bone-tumours, 20 
and this will allow us to (i) identify which dogs might be at risk and screen them regularly to 21 
detect bone-tumours early and (ii) develop new anti-tumour treatments based on genetics.  22 
 23 
The current study presents a comparison of bone-tumour risk levels between different dog 24 
breeds. Whereas previous studies identified high risk breeds for bone tumours, we also 25 
identify those breeds at lowest risk, meaning that  the breeds identified here could be 26 
compared to identify novel genetic differences which cause bone-tumours. In this study, we 27 
also compared various measures of body mass and leg length, and confirmed previous 28 
 4 
findings that heavier dogs with longer legs are at greatest risk of bone-tumours. This link 1 
between the biology of height and the biology of bone-tumours in dogs provides valuable 2 
avenues for further study into what causes bone-tumours to develop, and how we might treat 3 
them in the future.   4 
 5 
Article- 8087 words  6 
Background  7 
Osteosarcoma is an aggressive bone neoplasm occurring in dogs, which generally presents 8 
as lameness or pain associated with a bony or soft tissue mass or swelling (1). Pathological 9 
fracture is reported to occur in 38% of osteosarcoma cases (2, 3). Treatment for osteosarcoma 10 
can include amputation of the affected limb or resection of axial lesions, and adjuvant 11 
chemotherapy may be recommended (2, 4, 5). However, osteosarcoma often undergoes early 12 
haematogenous spread, and whilst just 10% of canine osteosarcoma cases present with gross 13 
metastases, 90% have been shown to possess microscopic metastatic disease at the time of 14 
diagnosis (1, 2, 4, 6). Therefore, whilst amputation is appropriately carried out as palliative 15 
surgery which will relieve pain, it is unable to prevent the metastatic spread which has already 16 
occurred in most osteosarcoma cases, and amputation therefore has little effect on survival. 17 
The lungs are the most common site of metastatic spread in canine osteosarcoma, and the 18 
median 1 year survival for dogs treated with amputation and chemotherapy is 45-50% (4, 6-19 
8). Since osteosarcoma causes severe pain, and current therapies offer little possibility of 20 
complete clinical cure, canine osteosarcoma represents a significant welfare threat to  21 
commonly affected breeds and a source of distress to owners (4, 6). 22 
 23 
Radiographically, canine osteosarcoma appears as lytic, proliferative or mixed bone lesions 24 
(4). Osteosarcoma is also categorised by anatomical site. The appendicular skeleton (limbs 25 
and pelvis)  represents the most common site of disease in large-breed dogs (95% of cases), 26 
whereas although only 5% of total osteosarcoma is reported to occur in dogs less than 15kg, 27 
more than 65% of small-breed osteosarcomas are located in the axial skeleton (head, cervical 28 
 5 
and spinal vertebrae, sternum and ribs) (2, 4, 6). A study of 85 appendicular osteosarcoma 1 
cases reported the most common lesion locations as the proximal humerus (26% of lesions), 2 
the distal radius (24%) and the distal tibia (15%), and multiple other analyses support this 3 
lesion distribution (1, 2, 4, 9). It is rare for osteosarcoma to be located as a mid-shaft lesion 4 
on any bone or near the elbow (2). Currently, standard practice is to confirm clinical and 5 
imaging diagnoses of osteosarcoma via fine needle aspirate or histopathology. Although 6 
pathologists utilise an agreed classification system for histological subtyping of osteosarcoma, 7 
there is disputed prognostic utility of the various histological grading schemes available (2, 4). 8 
 9 
Several dog breeds are reportedly predisposed to osteosarcoma, including the Rottweiler, 10 
Irish Wolfhound, Greyhound and Golden Retriever, and it has been shown that predisposition 11 
to osteosarcoma has a genetic basis in dogs (4, 5, 10-13). The majority of at-risk breeds 12 
possess large body mass, and fewer than 5% of osteosarcoma cases are reported in dogs 13 
under 15kg (14). It is therefore accepted that risk alleles for osteosarcoma may have become 14 
concentrated within certain breeds during selection for large body size (or, as some largeness 15 
alleles represent the ancestral wolf allele, non-selection for small body size) (10, 13). Such 16 
genetic variants may occur within genes which are the drivers of large body size or, 17 
alternatively, they may be variants in genes which do not functionally influence body size but 18 
which are inherited in linkage with largeness alleles (10, 13, 15). Findings from canine 19 
Genome Wide Association Studies (GWAS) of osteosarcoma imply that both modes of 20 
inheritance may apply for osteosarcoma risk alleles, and such studies have so far identified 21 
risk-associated polymorphisms at the Insulin Growth Factor-1 (IGF-1) locus, which is 22 
associated with large body size, and at other loci, such as the Cyclin Dependent Kinase 23 
CDKN2A/B region (4, 7, 10, 11, 13). However, only Irish Wolfhounds, Rottweilers and 24 
Greyhounds have been included in existing canine osteosarcoma GWAS, meaning that 25 
alternative causal variants in other breeds could have been missed while, to-date, protected 26 
breeds have been ignored altogether (10, 13, 16). Overall, the breed-associated genetics of 27 
osteosarcoma need to be examined in more detail in order to facilitate the discovery of novel 28 
 6 
osteosarcoma risk-associated genetic variants (17-19). Furthermore, the design of previous 1 
studies may have resulted in the underestimation of risk in common breeds, have ignored 2 
protected breeds, and have not included explicit conformational traits such as leg-length. The 3 
identification of novel demographic associations with osteosarcoma will permit the discovery 4 
of novel genetic variants, which in turn will enable polygenic risk models to be built, supporting 5 
the development of targeted osteosarcoma screening programmes, and permitting breeders 6 
to instigate responsible breeding practices, thus improving canine welfare (13). It will also 7 
provide the foundation for further studies to determine whether the variants associated with 8 
risk are situated within genes which drive osteosarcoma formation or progression, and 9 
therefore whether or not they are potential therapeutic targets (1).  10 
 11 
It is likely that additional non-genetic aspects of body size biology, such as epigenetics, along 12 
with the environment and nutrition during bone growth also combine with genetic 13 
predisposition to initiate osteosarcoma in large-breed individuals. This means that large breed 14 
genetics are necessary but not sufficient to induce osteosarcoma. However, non-genetic risk 15 
factors for canine osteosarcoma are poorly understood, and the identification of breeds 16 
predisposed to, and protected from, osteosarcoma will generate hypotheses for research in 17 
this field (16, 20). In humans, osteosarcoma is rare, affecting 3 individuals per million in the 18 
United States each year. However, since it affects adolescents and carries a prognosis of 60% 19 
to 70% 5 year survival amongst patients without disseminated disease, and 28% 5 year 20 
survival with metastases, osteosarcoma is an important cancer of unmet need (1, 21). Risk 21 
factors for human osteosarcoma appear to parallel those identified in dogs and include large 22 
birth weight, early pubertal growth and taller than average height (22). Studies aiming to 23 
predict osteosarcoma risk in humans have been hampered by small clinical sample sizes, and 24 
therefore canine studies with larger sample sizes have great potential to inform targeted 25 
human analyses which could produce advancements in early detection and intervention (1).  26 
 27 
 7 
Using anonymised veterinary clinical and demographic data from pathology records 1 
originating from VPG histology (23) and VetCompass™ (24), this study aimed to identify 2 
demographic risk factors for canine osteosarcoma with a particular focus on reporting both 3 
predispositions and protections associated with breed and conformation (25). Osteosarcoma 4 
of all anatomical sites was included in this study. The primary hypothesis of the current study 5 
was that, based on previous studies, the odds of osteosarcoma are higher amongst specific 6 
breeds such as Rottweilers, Scottish Deerhounds, Wolfhounds, Greyhounds and Golden 7 
Retrievers compared with crossbreds (4, 5, 16). Furthermore, it was hypothesised that 8 
purebred dogs in general have higher odds of osteosarcoma than crossbreds, since crossbred 9 
dogs made up only 19.2% of the total osteosarcoma case population in one study (5). Since 10 
reportedly predisposed breeds possess large body mass, a related hypothesis was that 11 
heavier weight categories have higher odds of osteosarcoma (2, 5, 10, 13, 26). Secondary to 12 
the breed and body mass hypotheses, we also proposed that dogs with conditions which 13 
become inherited during breeding for short leg length, such as chondrodystrophy, would be 14 
protected from osteosarcoma compared with non-chondrodystrophic breeds (27-29). This 15 
hypothesis was derived from the observation that human adolescents of greater than median 16 
height make up 62% of osteosarcoma cases (30). A separate hypothesis, unrelated to breed 17 
and conformation, was that older dogs have increased odds of osteosarcoma compared with 18 
younger animals. An association between age and canine osteosarcoma risk has been 19 
reported previously, and ageing is known to increase cancer-risk owing to mechanisms 20 
extensively reviewed elsewhere (5, 31, 32). 21 
The current study adds to the existing work on canine osteosarcoma by identifying protected 22 
breeds as well as those at-risk. In utilising a large sample size with a representative 23 
denominator population, we identified several new breed-associations not previously reported, 24 
and eliminated some of the bias associated with previous analyses in the field. Overall, we 25 
present novel breed and conformational associations with canine osteosarcoma of all 26 
anatomical sites and provide suggestions for avenues of further work.  27 
 28 
 8 
Results  1 
Description of Study Populations and Univariable Logistic Regression Modelling 2 
The study included 1756 osteosarcoma cases from the VPG histology dataset and 905,211 3 
controls from the VetCompass dataset. Osteosarcomas were not subdivided by location for 4 
analysis, however the distribution of locations included in the case dataset is shown in Figure 5 
1. Amongst the VPG histology cases, 45.50% were appendicular (799), 16.00% were axial 6 
(282), 8.37% were extraskeletal (147) and 30.06% were of unrecorded location (528 cases).  7 
 8 
Of cases, 21.10 % (370) were crossbred and 77.40 % (1359) were purebred whereas 27.20% 9 
(245889) of non-cases were crossbred and 72.4% (655266) were purebred. The remaining 10 
cases and controls were of unknown breed (Table 1). The 5 most common breeds amongst 11 
cases were Crossbred (n = 300, 17.1%), Labrador Retriever (n = 260, 14.8%), Rottweiler (n = 12 
139, 7.9%), Greyhound (n = 103, 5.9%), German Shepherd dog (n = 65, 3.7%) and Golden 13 
Retriever (n = 65, 3.7%). The most common breeds amongst non-cases were Crossbred (n = 14 
197549, 21.8%), Labrador Retriever (n = 59925, 6.6%), Staffordshire Bull Terrier (n = 53934, 15 
6.0%), Jack Russell Terrier (n = 48569, 5.4%) and Cocker Spaniel (n = 33073, 3.7%) (Table 16 
1). Amongst cases, the most common Kennel Club (KC) breed group was Gundog (n = 484, 17 
27.6%) whereas amongst non-cases Terriers were the most common group (n = 145828, 18 







Figure 1: Location distribution for lesions biopsied from 1756 osteosarcoma cases 3 
included in the current analysis. A. Lesions were categorised as originating from the 4 
 10 
appendicular skeleton (limbs and pelvis), axial skeleton (head, cervical and spinal vertebrae, 1 
sternum and ribs). Extraskeletal osteosarcomas were those not originating from any bony 2 
tissue. The lesion location was not recorded for 528/1756 cases. B. Osteosarcoma lesions 3 
were categorised based on the tissue of origin. Those locations with less than 1 case were 4 
grouped as “other” and included 1 renal, 7 hepatic, 3 pulmonary, 1 bladder, 2 gastrointestinal, 5 
1 pleural, 1 thyroid, 1 aortic, 1 jugular groove, 1 lymph node, 1 ocular, 2 fibula, 2 metacarpal 6 



















Of case dogs, 6.0% (106) were brachycephalic, 19.4% (341) were dolichocephalic, and 55.9% 26 
(982) were mesocephalic. Amongst non-cases, 18.4% (166883) were brachycephalic, 8.4% 27 
(75770) were dolichocephalic and 50% (452296) were mesocephalic (Table 1). The sex-28 
 11 
neuter variable was divided into five categories, of which the most cases were male-neutered 1 
(574 dogs, 32.7%) and most non-cases were male-entire (259460, 28.7%) (Table 1). 2 
chondrodystrophic dogs represented 9.4% of cases (165) whereas amongst non-cases 36.7% 3 
(331858 dogs) were chondrodystrophic (Table 1). All variables assessed in univariate 4 
modelling were associated with osteosarcoma with a global variable p-value of <0.05, and 5 
were therefore included in multivariate logistic regression modelling (Table 1).  6 
Briefly, univariate regression calculated the odds ratio of osteosarcoma associated with 7 
categories (e.g. Rottweiler, <3 years, male-neutered) within different variables (e.g. breed, 8 
age and sex-neuter status) but did not condition the odds ratios for any variable on the effect 9 
of other variables present in the analysis. For example, the effect of different ages on 10 
osteosarcoma was not taken into account when considering the effect of different breeds. This 11 
analysis was carried out to obtain a global p-value for each variable, identifying those strongly 12 
associated with an altered risk of osteosarcoma, in order to carry such variables forward into 13 
multivariate analysis. A global p-value was calculated by comparing the model which 14 
contained each variable e.g. breed, to a null model without a breed variable (but with all the 15 
other variables intact), using ANOVA.  16 
In multivariate modelling, the odds ratio of osteosarcoma in each category of the variable e.g. 17 
breed was calculated conditional on the concurrent effects of the non-breed related factors of 18 
sex-neuter and age. Again, the global effect of each entire variable was then calculated by 19 
comparing the model containing the breed variable to a model without breed but with all other 20 
variables intact. In multivariate modelling, the global variable p-value is determined using a 21 
likelihood ratio test for comparison of multivariate models. Other breed-related variables 22 
(which could not be put into the same model as breed, owing to their high correlation with 23 
breed) then replaced breed in the multivariable model such that purebred-status, KC breed 24 
group, body mass, dachshund status, spaniel status, chondrodystrophy status and skull-25 
shape were considered one at a time in a model with age and sex-neuter status.  A study-26 
wide significance threshold of p<0.05 was used without adjusting for multiple comparisons 27 
since a Bonferroni correction is overly stringent for correlated variables (33).  28 
 12 
 1 
Table 1 Descriptive statistics and univariable logistic regression results identifying 2 
demographic risk factors of osteosarcoma in UK dogs 3 
 4 
NB. Table 1 is located at the end of the document owing to it being greater than 1 A4 5 
page in length 6 
 7 
Legend: 8 
Descriptive statistics and univariable logistic regression results calculated using cases 9 
submitted to VPG histology between 2008 and 2020, and controls enrolled in the 10 
VetCompass™ programme during 2016. Percentages represent percentage of the total 11 
study population. The breed percentages separated by case and non-case are listed in 12 
Supplementary Data Table S1.  Results determine associations between demographic 13 
















Multivariable Logistic Regression Modelling  1 
Breed- related associations 2 
The final breed model retained breed, age, and sex/neuter status (Figure 2 and Table 2A). The 3 
area under the ROC curve was 0.912, indicating a good model fit. After accounting for the 4 
effect of the other variables, 27 breeds had increased odds of osteosarcoma compared with 5 
crossbred dogs. Breeds with the highest odds ratios (OR) were Rottweiler (OR 13.30, 95% 6 
confidence interval (CI) 10.55 - 16.75), Rhodesian Ridgeback (OR 11.31, 95% CI 7.37 - 7 
17.35), Great Dane (OR 10.03, 95% CI 5.81 - 17.32) and Mastiff (OR 9.09, 95% CI 6.06 - 8 
13.65). The Dalmatian had an OR of 1.00 compared to crossbreds. Thirty breeds had reduced 9 
odds of osteosarcoma compared with crossbred dogs. Of these, 16 breeds had zero cases 10 
and therefore confidence intervals could not be estimated for the OR of osteosarcoma these 11 
breeds. Of those breeds with at least one case, those with the lowest odds ratios of 12 
osteosarcoma included Jack Russell Terrier (OR 0.38, 95% CI 0.26 - 0.54), Border Terrier 13 
(OR 0.35, 95% CI 0.16 - 0.81), Bichon Frise (OR 0.30, 95% CI 0.14 - 0.64), French Bulldog 14 
(OR 0.30, 95% CI 0.11 - 0.83) and Cavalier King Charles Spaniel (OR 0.21, 95% CI 0.10 - 15 
0.46) (Table 2A, Figure 2). 16 
 17 
As described in the methods, breed-linked variables (purebred-status, Kennel Club breed 18 
group, body mass, dachshund-status, spaniel-status, chondrodystrophy-status and skull-19 
shape) individually replaced the breed variable in the final multivariable model to evaluate the 20 
association of these risk factors with osteosarcoma whilst accounting for other confounding 21 
variables (Table 2B). Of particular interest were variables relating to both breed and 22 
conformation, since the main breed multivariable logistic regression model in the current study 23 
showed that many of the predisposed breeds were large breeds whilst many of the protected 24 
breeds were small breeds. 25 
When body mass was used in multivariable logistic regression modelling in place of breed, 26 
dogs with body mass <10kg had the lowest odds of osteosarcoma. The odds of osteosarcoma 27 
progressively increased with body size such that dogs >40kg had the highest odds of 28 
 14 
osteosarcoma when compared with <10kg (OR 18.07, 95% CI 13.87 - 23.53). The relationship 1 
between body mass and osteosarcoma risk is clearly seen when the OR and mean body mass 2 
for each breed are plotted (Figure 3). Purebred dogs had an OR of 1.25 for osteosarcoma 3 
(95% CI 1.11–1.41) compared with crossbred dogs. Dachshund breeds (OR 0.15, 95% CI 4 
0.05 - 0.46), Spaniel breeds (OR 0.37, 95% CI 0.29 - 0.47) and chondrodystrophic breeds 5 
(OR, 0.13, 95% CI 0.11 - 0.16) were all associated with reduced risk of osteosarcoma when 6 
compared with non-Dachshund, non-Spaniel and non-chondrodystrophic breeds respectively 7 
(27-29). Dolichocephalic dogs (OR 1.92, 95% CI 1.68 - 2.19) had increased odds of 8 
osteosarcoma when compared with mesocephalic dogs, supporting the finding that dogs in 9 
the KC hound group, where longer skull-shape predominates, possess the greatest 10 
osteosarcoma odds of all KC groups (OR 21.54, 95% CI 14.14-32.81). Of the other Kennel 11 
Club breed groups, all showed increased odds of osteosarcoma when compared to the toy 12 
breed group. Brachycephalic dogs (OR 0.39, 95% CI 0.32 - 0.48) were protected when 13 
compared with mesocephalics, whereas dolichocephalic dogs are at increased risk compared 14 
to mesocephalics, suggesting a linear relationship between nose-length and osteosarcoma 15 
risk. This relationship may occur secondary to the generally smaller body mass of 16 
brachycephalic breeds; however, it is interesting to note that the heavy Dogue de Bordeaux, 17 
which has a brachycephalic skull shape, does not have an elevated osteosarcoma risk 18 
comparable to dogs of a similar mass (for example, the mastiff; Figure 3).  19 
 20 
Non-breed related associations 21 
The odds of osteosarcoma were highest amongst dogs 9 to <12 years (OR 18.44, 95% CI 22 
14.59 - 23.30) compared with dogs <3 years old. The sex-neuter category at greatest risk of 23 
osteosarcoma was neutered males (OR 9.39, 95% CI 6.83- 12.91) compared with entire 24 
female dogs (34). (Table 2A). 25 
 26 
Table 2 - Multivariable logistic regression results for variables significantly associated 27 
with diagnosis of osteosarcoma amongst UK dogs. 28 
 15 
 1 
NB. Tables 2A and 2B are located at the end of the document owing to them being 2 
greater than 1 A4 page in length 3 
  4 
Legend:  5 
Full multivariable logistic regression results for variables significantly associated with 6 
diagnosis of osteosarcoma amongst UK dogs. The main model included breed-name 7 
as the breed variable (Table 2A), and six breed-related variables (purebred-status, 8 
Kennel Club breed group, body mass, dachshund-status, spaniel-status, 9 
chondrodystrophy status) then replaced breed-name in the model (Table 2B). Cases 10 
were dogs with osteosarcoma confirmed by analysis of biopsies submitted to VPG 11 
histology between 2008 and 2020 and controls were dogs enrolled in the VetCompass™ 12 

















Figure 2: Breed multivariable logistic regression results. Forest plot of Odds Ratios (± 3 
95% confidence intervals) for osteosarcoma risk by dog breed, from multivariate analysis 4 
(Table 2) accounting for age and sex/neuter status. Cases were dogs with osteosarcoma 5 
confirmed by analysis of biopsies submitted to VPG histology between 2008 and 2020 and 6 




Figure 3: Breed skull shape and OR for osteosarcoma risk (from Table 2 multivariate 2 
analysis) plotted against mean body mass. Body mass was calculated as the mean of the 3 
VetCompass estimates of average mass for males and females of each breed. Ak(u), Akita 4 
(Unspecified); AM, Alaskan Malamute; AB, American Bulldog; Be, Beagle; BF, Bichon Frise; 5 
BC, Border Collie; BT, Border Terrier; Bo, Boxer; Bu(u), Bulldog (Unspecified); CT, Cairn 6 
Terrier; CKCS, Cavalier King Charles Spaniel; CS, Cocker Spaniel; Co(u), Collie 7 
(Unspecified); Da, Dalmatian; DdB, Dogue de Bordeaux; ESS, English Springer Spaniel; FT, 8 
Fox Terrier; FB, French Bulldog; GP(u), German Pointer; GSD, German Shepherd Dog; GR, 9 
Golden Retriever; GD, Great Dane; Gr(u), Greyhound (Unspecified); HV, Hungarian Vizsla; 10 
Hu, Husky; JRT, Jack Russell Terrier; La, Labradoodle; LR, Labrador Retriever; Lu, Lurcher; 11 
Ma(u), Mastiff (Unspecified); Pi(u), Pinscher (Unspecified); Po(u), Poodle (Unspecified); RR, 12 
Rhodesian Ridgeback; Ro, Rottweiler; ST, Scottish Terrier; SBT, Staffordshire Bull Terrier; 13 
 18 
SP, Standard Poodle; TT, Tibetan Terrier; We, Weimaraner; WHWT, West Highland White 1 
Terrier; Wh, Whippet. 2 
 3 
Discussion  4 
This study aimed to identify associations between demographic risk factors and osteosarcoma 5 
risk amongst UK dogs. A primary focus was placed on breed-related factors in order to 6 
facilitate better evidence-based veterinary care, to inform breeding practices, and to generate 7 
hypotheses about the genetic basis of osteosarcoma predisposition. Many of the previous 8 
studies that examined the epidemiology of canine osteosarcoma were limited because; they 9 
utilised entirely secondary care datasets, total study population numbered fewer than 1000 10 
dogs, they often did not have a comparator non-case group, and many were based solely in 11 
the USA, where the breed risk of osteosarcoma may differ to the UK (2, 3, 5, 8, 12). The 12 
current study benefitted from inclusion of a large number (1756) of osteosarcoma cases 13 
confirmed through analysis of data associated with biopsy samples submitted from veterinary 14 
practices to VPG Histology, Bristol, UK (23). The study additionally benefitted from a control 15 
group of 905,211 dogs registered in primary care veterinary practices across the UK within 16 
the VetCompass project so that the results could be generalisable to the wider vet-attending 17 
dog population (24, 25). Although univariable and multivariable regression analyses were 18 
used to determine the effect of demographic risk factors on the odds of osteosarcoma, only 19 
the multivariable results will be discussed because these accounted for the confounding 20 
effects of other variables. This study therefore represents one of the largest published studies 21 
to estimate the effect of breed-related traits on osteosarcoma in dogs under veterinary care in 22 
the UK, and provides important novel information for veterinarians, breeders and researchers.  23 
 24 
Purebred Variable 25 
The current study included both purebred and crossbred dogs. We reported higher odds of 26 
osteosarcoma amongst purebred dogs compared with crossbreds, which supports the 27 
hypothesis that osteosarcoma is a breed-associated disorder.  28 
 19 
 1 
Breed Variable 2 
After accounting for other variables, 23 breeds with more than 4 cases and more than 1000 3 
controls showed elevated odds of osteosarcoma compared to crossbreds and, of these 4 
breeds, the Rottweiler, Rhodesian Ridgeback and Great Dane had over ten times the odds. 5 
Although the Rottweiler and Great Dane have been reported as at-risk breeds previously, the 6 
current study is the first to identify predisposition for the Rhodesian Ridgeback (2, 4, 5, 10, 12, 7 
13, 26). Rhodesian Ridgebacks could have been omitted from previous work owing to 8 
selection bias, which refers to a scenario in which the composition of the study group differs 9 
from the source population, and this biases the association between exposure and outcome 10 
(35, 36). Selection bias exists within studies in which all participants are cases, and in which 11 
a control population is not included. Such studies may be unable to distinguish between 12 
breeds which represent a high proportion of the caseload of osteosarcoma owing to the 13 
popularity of the breed, and those which represent a high proportion of the caseload because 14 
the breed is genetically predisposed to osteosarcoma (35). For example, Rhodesian 15 
Ridgebacks are owned by a lower proportion of the general population than Rottweilers (1.7% 16 
Rhodesian Ridgeback versus 7.9% Rottweiler ownership within VetCompass), which could 17 
have led to case-only studies underestimating the prevalence of osteosarcoma within 18 
Rhodesian Ridgebacks, because they present less often to the clinic owing to reduced 19 
ownership (5). Having used a case and a control population, the current study design enabled 20 
us to minimize the likelihood of selective sampling, therefore we demonstrated that, as a 21 
proportion of Rhodesian Ridgebacks owned, their osteosarcoma risk is actually high (35, 37). 22 
Our results also differ from previous studies which determined that Staffordshire Bull Terriers 23 
(SBT) commonly present to veterinary clinics with osteosarcoma, and therefore cited SBT as 24 
an at-risk breed (5). Using a control population of UK owned dogs without osteosarcoma 25 
enabled us to show that the presence of SBT in controls relative to cases (SBT are one of the 26 
5 most-owned breeds in the VetCompass control dataset) means that as a proportion of total 27 
 20 
SBT owned, their osteosarcoma risk is actually small. These findings highlight the requirement 1 
for control samples when reporting demographic risk factors of disease (36).  2 
 3 
The findings of the current study contrast with one of the largest published analyses of 4 
osteosarcoma risk, in which breeds were grouped according to Parker’s genomic classification 5 
of dog breeds (5, 38). In the previous analysis, mastiff-terrier type breeds were shown to have 6 
the highest odds of osteosarcoma of all breed groups, however, applying Parker’s 7 
classification to the current study shows that the most at-risk breeds (the Rottweiler and the 8 
Great Dane) fell into the mountain breed category (5, 38, 39). The incorporation of age into 9 
the breed model in the current study might explain why mountain breeds are shown to be 10 
more at risk, since the previous study noted that osteosarcoma occurred at different ages in 11 
the different breed groups, but did not include age as a covariate (5). Furthermore, selection 12 
bias is likely to have posed a problem in the previous study, which did not incorporate a control 13 
population and used cases in secondary care rather than a mixed primary and secondary care 14 
population (5).  15 
Although the current study includes all locations of osteosarcoma, and there are recognised 16 
differences in the breed-associations with different locations, the current work does include a 17 
spread of appendicular, axial and extraskeletal tumours in order to examine the overall 18 
associations between demographic risk factors and osteosarcoma as a whole (1, 9). Further 19 
work will address the location-specific demographic risk factors for osteosarcoma. However, 20 
this approach was not taken in the current study because location information was not 21 
available for over 500 out of the 1756 cases and excluding these cases would have diminished 22 
the power of this analysis.  23 
A novel aspect of the current study was the effort to identify breeds protected from 24 
osteosarcoma. It is important to identify protected breeds because their genetics could be 25 
compared with the genetics of at-risk breeds to identify allelic variants associated with 26 
osteosarcoma risk and protection (1). Several studies acknowledge that inheritance of 27 
osteosarcoma cannot be attributed to a single highly penetrant, large effect genetic variant, 28 
 21 
but rather adheres to a polygenic risk model associated with inheritance of multiple low 1 
penetrance, small effect variants (10). Improved understanding of such variants and how they 2 
influence osteosarcoma risk (both increasing and decreasing) is fundamental for developing 3 
osteosarcoma prevention and therapy (1, 13, 16, 20, 40, 41). In the current study, 30 breeds 4 
had reduced odds of osteosarcoma compared with Crossbreds. Of these, 16 had zero cases 5 
and therefore, although they were retained in the final model, confidence intervals could not 6 
be calculated for the odds of osteosarcoma amongst these breeds. However, given that each 7 
of these breeds was represented by at least 1000 dogs in the VetCompass control population, 8 
this is highly suggestive of them having reduced osteosarcoma risk. Amongst breeds with at 9 
least one case, the Jack Russell Terrier, Border Terrier, Bichon Frise, French Bulldog and 10 
Cavalier King Charles Spaniel had the lowest odds of osteosarcoma compared with crossbred 11 
dogs. Consistent with our findings that breeds with large body mass are at increased risk of 12 
osteosarcoma, the protected breed list comprises breeds of small body mass. Similarly, the 13 
Toy KC breed group had the lowest odds of osteosarcoma out of all KC groups. Therefore, 14 
the findings of the current study overwhelmingly suggest that protection from osteosarcoma 15 
is associated with small body mass. However, despite this finding, there were still some small 16 
breeds such as the Scottish Terrier, Cairn Terrier and Whippet that were not protected from 17 
osteosarcoma compared to crossbreds. Comparison of the genetics between these small, 18 
breeds against small breeds which are breeds could point to novel aspects of risk-associated 19 
genetic biology for osteosarcoma which occurs independently of body mass.  20 
 21 
The effects of chondrodystrophy were analysed as an alternative approach towards exploring 22 
associations between body conformation, and osteosarcoma protection. It has been 23 
postulated that inheritance of genetic variants predisposing to excessive long bone length and 24 
rapid limb growth could underlie the causal biology of osteosarcoma in both humans and dogs. 25 
Indeed, in one study, 62% of adolescents with osteosarcoma were shown to be above median 26 
height for their age group (22). Although exact limb length data was not available in the current 27 
study, a chondrodystrophy variable was incorporated, as a way of attaining published data 28 
 22 
about which breeds carry polygenic inheritance of short limb length. The best characterised 1 
genetic mutation used as a robust marker of chondrodystrophy is an autosomal dominant 2 
fibroblast growth factor (FGF) 4 mutation in chromosome 12 (FGF4L2) that was identified in 3 
GWAS of canine limb dysplasia (42). Breeds in which the FGF4L2 mutation is fixed exhibit a 4 
phenotype of extremely short long bones, and intervertebral disc disease (27). Although 5 5 
other FGF4 retrogenes have been sequenced in dogs, and are also known to affect limb 6 
morphology, their frequency of carriage in various canine breeds has not yet been studied 7 
therefore chondrodystrophic breeds in the current study were defined as those with published, 8 
high-frequency carriage of the FGF4L2 gene (42). 9 
 10 
Chondrodystrophic breeds, Spaniel-type breeds and Dachshund-type breeds carry the 11 
FGF4L2 mutation at high frequency, and all of these breed-types were associated with 12 
protection from osteosarcoma in the current analysis (27-29). Interestingly, both Cairn and 13 
Scottish terriers have been shown to carry chondrodystrophy variants at very low allele 14 
frequencies (0 and 0.4 respectively), supporting the inverse relationship we observe between 15 
chondrodystrophy gene carriage and osteosarcoma risk, since Cairn and Scottish terriers 16 
were not protected from osteosarcoma compared to crossbreds where other small breeds 17 
were protected (27, 29, 43). This inference must be made with caution however, as allele 18 
frequencies for chondrodystrophy genetic variants have only been calculated using low 19 
numbers of animals in these breeds to-date. Nonetheless, the current analysis suggests that 20 
small chondrodystrophic dogs may be at lower risk of osteosarcoma compared with small, 21 
non-chondrodystrophic dogs, implying that certain routes of breeding for small size, including 22 
those related to chondrodystrophy, have resulted in the loss of osteosarcoma risk-associated 23 
alleles, whereas others have not (29). Similarly, brachycephalic dogs were shown to have 24 
lower odds of osteosarcoma when compared with mesocephalic or dolichocephalic animals. 25 
These results suggest that those individuals with a combination of genetic variants mediating 26 
chondrodystrophy or brachycephaly also appear to possess a combination of genetic variants 27 
which are associated with protection from osteosarcoma. Previously it was not known whether 28 
 23 
these two sets of variants were one and the same, however current studies suggest that at 1 
least some of those variants which functionally mediate body conformation also functionally 2 
affect bone homeostasis and osteosarcoma development.   3 
 4 
The presence of an FGF4 retrotransposon associated with appendicular chondrodysplasia 5 
also reduces neurocranium size (44, 45), meaning that many chondrodystrophic breeds are 6 
also brachycephalic. Furthermore, a missense mutation in bone morphogenetic protein (BMP) 7 
3 is associated with brachycephaly (45, 46) and the presence of a transposable element 8 
insertion in SPARK-related modular calcium binding protein (SMOC) 2 gene, which 9 
suppresses BMP pathway activity (47, 48), was reported to account for 36% of facial length 10 
variation in brachycephalic dogs (44). Deregulated BMP and FGF signalling are associated 11 
with osteosarcoma; and FGF and BMP signalling are known to regulate the development of 12 
mesenchymal stem cells to immature and mature osteoblasts, and subsequent skeletal 13 
homeostasis (49). These studies suggest brachycephalic skull shape or chondrodystrophy 14 
may both be traits which are markers of reduced activity of signalling pathways, in particular 15 
FGF and BMP signalling, which tend to promote osteosarcoma development. Notably, the 16 
current study highlighted that Dogue de Bordeaux are a brachycephalic breed  in which odds 17 
of osteosarcoma are not significantly different to the baseline crossbred population, despite 18 
being genetically predisposed to large body mass. Although the reduction in osteosarcoma 19 
risk associated with brachycephalic breeds is of scientific interest, selective breeding to 20 
enhance brachycephalic traits is not a viable means of reducing canine osteosarcoma risk, 21 
since brachycephalic obstructive airway syndrome is a significant welfare concern which is 22 
perpetuated by breeding for short skull shape. Furthermore, it is important to emphasise that 23 
‘reduced risk’ does not equate to ‘no risk’ and brachycephalic dogs can still get osteosarcoma. 24 
Increasing body mass was shown to be progressively associated with increasing odds of 25 
osteosarcoma. An association between large body mass and osteosarcoma risk could occur 26 
because allelic variants which mediate osteosarcoma risk are inherited along within or along 27 
with genetic variants mediating large body size, as discussed above in relation to limb stature. 28 
 24 
However, it should be remembered that neoplasia is a multifactorial condition, and epigenetic 1 
and environmental factors associated with giantism could also underlie the strong association 2 
between osteosarcoma risk and large body size in dogs (8, 16, 40, 50). The results of the 3 
current study suggest that larger body size is necessary but not sufficient to produce a high 4 
risk (more than ten times the odds of crossbreds) of osteosarcoma, since all breeds in the 5 
highly-at risk group have large body mass, however some breeds which attain large body 6 
mass, such as the Dogue de Bordeaux and the Alaskan Malamute, have very low odds of 7 
osteosarcoma. These findings support a mechanism whereby osteosarcoma risk-associated 8 
genetics are inherited in some large breeds and absent in others, whilst the environment 9 
generated by large-breed biology may also interact with such genetic variants in order to 10 
produce osteosarcoma. Larger GWAS comprising both at-risk and protected breeds are 11 
required in order to interrogate the genetic determinants of osteosarcoma risk and protection 12 
more fully. Whilst some studies have taken the view that breed and body mass are separate 13 
variables, in the current study we took body mass to be a breed-associated variable which 14 
replaced breed in the final multivariate analysis instead of being included as a covariate. This 15 
decision was taken because breed standards specify body mass parameters, therefore 16 
genetic variants which mediate body mass are inherently part of each breed, and this concept 17 
was supported statistically because if body mass and breed were included in the same model, 18 
the VIF score for collinearity carried a p-value of <2.2 x 10-16 suggesting significant 19 
multicollinearity between variables (51).  20 
 21 
All older age groups had higher odds of osteosarcoma compared with dogs under 3 years of 22 
age. However, dogs over twelve years old showed lower odds of osteosarcoma than those 23 
aged between nine and twelve. Although osteosarcoma reportedly occurs with higher 24 
prevalence amongst younger animals when compared to other neoplasms, the current 25 
literature suggests that, like most neoplasms, its incidence increases with age, which may be 26 
a result of cellular ageing and mutational accumulation (2, 4, 8, 11, 40, 52, 53). Previous 27 
studies have shown a bi-modal distribution of age of onset in osteosarcoma, in which at-risk 28 
 25 
breeds experience younger age of disease onset (5) and although this was not evident in our 1 
analysis of age by categorical variables, when considered as a continuous variable there is a 2 
small peak in the number of cases in the second year of life (Supplementary Figure S8). This 3 
parallels the human syndrome whereby genetically at-risk adolescents experience early-onset 4 
osteosarcoma, whilst a second population of individuals experience the disease during old-5 
age  (54). Since all osteosarcoma cases are, by definition, cases of neoplasia, further studies 6 
utilizing a control population of canine patients with any neoplastic lesion, and a case 7 
population of osteosarcoma patients, would allow us to determine whether the effects of age 8 
seen in the current study are an osteosarcoma-specific effect or are generally applicable to all 9 
neoplasms. The current analysis may have underreported the odds of osteosarcoma amongst 10 
the oldest dogs for several reasons. Firstly, we and others have shown osteosarcoma to be a 11 
cancer of large and giant breed dogs (2, 4, 5, 10). Large breeds are known to have shorter 12 
average lifespans than smaller dogs, therefore nine to twelve years is the age category of 13 
highest risk for osteosarcoma in the current analysis, because it reflects the age at death of 14 
the high risk breeds for osteosarcoma (55, 56).  Secondly, the current study  may be 15 
confounded by selection bias, because all cases of osteosarcoma in the current study were 16 
diagnosed by biopsy (35). Elderly veterinary patients may be less likely to receive 17 
histopathological analysis of suspected osteosarcoma lesions because the disease is 18 
associated with poor prognosis and requires aggressive surgical intervention (1, 2, 5, 12). 19 
Therefore, owners may opt for euthanasia of elderly animals with osteosarcoma more 20 
frequently than those with other cancers such as lymphoma, in which less invasive palliative 21 
treatment options, such as orally administered chemotherapies, are available (57). Hence, 22 
samples from the over twelve years age group may be underrepresented within the VPG 23 
histopathology cases in the current analysis, creating a selection bias. A more detailed 24 
analysis of veterinary diagnostic decision making in different tumour settings is required to 25 
determine whether this reasoning is valid.  26 
 27 
 26 
Our results relating to the effects from sex and neutering status supported the current literature 1 
that suggests that male animals have increased risk of osteosarcoma compared with females, 2 
and that neutered animals of both sexes are more at risk of osteosarcoma compared to their 3 
entire counterparts (5, 40, 58). There is evidence to suggest that reduced levels of circulating 4 
gonadal hormones may be associated with increased osteosarcoma risk (58). However, in the 5 
current analysis and in published studies there are many confounding factors that prevent the 6 
establishment of a causal role for neutering in osteosarcoma (58, 59). Importantly, dogs 7 
needed to have undergone biopsy for histological analysis to appear in the VPG dataset used 8 
in the current study, suggesting a population derived from either insured animals or animals 9 
owned by owners who have financed surgical intervention. Data derived by Sánchez-Vizcaíno 10 
et al. demonstrated that dogs had significantly increased odds of being neutered if their owners 11 
lived in in areas of more affluent socio-economic status according to IMD income deprivation 12 
indices (OR 1.90 for male dogs, OR 2.19 for female dogs) (60). Therefore, neutered animals 13 
may be more likely to be owned by owners who are able to finance tumour biopsy, and the 14 
socio-economic status of ownership could confound any associations determined between 15 
neutering and osteosarcoma risk in the current analysis (60). Repeating this analysis using 16 
osteosarcoma cases from a dataset which allows an even spread of IMD-ranked postcodes 17 
to be selected may help to address the role of neutering in osteosarcoma risk (24, 25). Owner 18 
socio-economic status may also have affected the purebred versus crossbred analysis, or 19 
indeed the individual breed analysis since the same study also shows that purebred animals 20 
are more likely to be owned by more affluent owners than crossbred animals, as are certain 21 
breeds, therefore purebreds or breeds favoured by a certain owner demographic could be 22 
overrepresented in the VPG histology caseload (60). Other experimental and genetic 23 
epidemiological methods may be able to interrogate a causal role of gonadal hormone levels 24 
in disease amongst canine populations in the future, although owing to the relatively low 25 
incidence of osteosarcoma within both canine and human populations, the sample sizes 26 
available to such studies are currently too small to ensure adequate experimental power (52).  27 
 27 
Further work should consider the differences between appendicular and axial osteosarcoma. 1 
Although the various osteosarcoma subtypes are thought to share a common cell of origin, 2 
this field is poorly understood, and the demographic risk factors for disease may be different 3 
for osteosarcoma when categorised by anatomical location as opposed to osteosarcoma as 4 
a whole (61).  5 
An important point to note regarding all of the findings of the current study are that, whilst 6 
certain demographic risk factors are associated with protection from osteosarcoma, dogs of 7 
small mass, or protected breed, or with brachycephalic confirmation can still get 8 
osteosarcoma. Owners and vets should not interpret the findings of the current work to mean 9 
that low-risk dogs are completely protected from disease.  10 
 11 
Limitations 12 
In case-control studies, ideally the controls represent the population from which cases are 13 
derived. Although in the current analysis this was not fully possible, cases were derived from 14 
laboratory samples submitted from primary and secondary care veterinary practices, and 15 
controls from VetCompass dogs registered with primary care practices. It was thus considered 16 
likely that the VetCompass population was a good estimation of the background veterinary 17 
attending population from which the cases originated (62). However, selection bias may have 18 
affected the cases whereby only osteosarcoma cases with histologically confirmed diagnoses 19 
were included, and these cases may not be selected at random from the true overall UK 20 
caseload of canine osteosarcoma cases.  21 
 22 
Unmeasured confounding factors may also have influenced the results of the current study 23 
because the datasets were acquired over different timescales, and it is not possible to 24 
determine the effects of this sampling method on the results obtained. The VetCompass 25 
control dataset provides a snapshot of clinic-registered dogs in 2016, whereas the VPG 26 
dataset of osteosarcoma cases spans the years 2008-2020. Certain breeds such as 27 
brachycephalics and designers had become more popular by 2016, which may make these 28 
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breeds underrepresented in data from earlier years (63-66). Thus, such breeds are less likely 1 
to feature in the VPG osteosarcoma cases versus the 2016 VetCompass control population, 2 
lowering their apparent odds of osteosarcoma. However, if the popularity of these breeds 3 
continued to rise between 2016 and 2020, the presence of more recent cases in the VPG 4 
osteosarcoma case dataset may offset this effect, since it spans 2008-2020. A more accurate 5 
quantification of owned breeds across several years is required to determine the true effect of 6 
breed popularity over time on the current study, and repeating the current study using only 7 
VetCompass data from 2016 would be advantageous as a comparator for the results 8 
presented here. Other factors such as socio-economic status of owners submitting biopsies, 9 
and age structure of the breed amongst UK dogs may also have confounded the current study 10 
(36).  11 
The current study did not account for the expected breed lifespan when considering 12 
demographic risk factors for cancer. However, as alluded to in the discussion of the effect of 13 
age on osteosarcoma, various factors such as breed and neuter status may affect the years-14 
at-risk of dogs, and thus certain breeds with longer lifespans, or neutered dogs (shown to live 15 
longer on average) may appear to be more at risk of osteosarcoma simply because they 16 
experience more years-at risk of disease (67). The inclusion of this complex variable was 17 
beyond the scope of this study because a reliable published lifespan could not be sourced for 18 
all of the included breeds, however future analyses considering years-at-risk would be 19 
valuable for validation of the conclusions presented here.  20 
 21 
Crossbred dogs were used as the comparator for breed-associated risk of osteosarcoma in 22 
the current study. This approach uses a precedent established by other studies utilising 23 
VetCompass data, whereby the large number of dogs included in the denominator population 24 
is considered sufficient to ensure that the crossbred population studied accurately represents 25 
the overall crossbred population of UK dogs, and that similarly powered studies could replicate 26 
the analysis with a crossbred comparator (68-71). Crossbreds are a useful comparator for 27 
confirmation-related disorder because they comprise variable inheritance of genetic 28 
 29 
determinants of bodyweight, skull shape and conformation, and they make up the most owned 1 
population of the VetCompass denominator dataset. Although crossbreds are often assumed 2 
to have hybrid-vigour derived from non-selective breeding, a lack of specificity in breeding 3 
practices could also lead to animals perceived as less desirable being used in crosses, making 4 
their disease-risk scientifically interesting (68).    5 
Breeds with <1000 control animals in the current study were combined into a category entitled 6 
“Other Purebred”. This variable was associated with a lower risk of osteosarcoma than the 7 
crossbred breed category, however combining multiple breeds with varying osteosarcoma 8 
risks did not produce an informative result for further research. This strategy was taken to 9 
permit the inclusion of all cases in the statistical model. Similarly, breeds with <4 cases of 10 
osteosarcoma or <1000 controls were also combined into the “Other Purebred” variable, in 11 
order to avoid overestimation of odds due to the presence of uncommon breeds with a single 12 
case in the dataset. Excluding breeds with low numbers of dogs in this manner did result in 13 
the loss of certain breeds from the analysis, including Irish Wolfhounds and Scottish 14 
Deerhounds, which previous studies have shown to be predisposed to osteosarcoma. 15 
However, estimates of osteosarcoma risk for the full list of breeds with any number of cases 16 
are provided in supplementary table S2 and supplementary table S1 shows the full case and 17 
control population by breed. This information may be of interest to breeders and researchers 18 
with a focus on particular uncommon breeds. We also included an unrecorded category for 19 
each variable, to ensure that every case appears complete in statistical analysis. This avoids 20 
bias induced by omitting incomplete records, since a higher proportion of VPG histology cases 21 
were lacking variable information when compared to VetCompass cases. However, because 22 
of this discrepancy in the percentage of unrecorded entries between datasets, the category 23 
“variable unrecorded” had altered ORs of osteosarcoma when compared to the base category. 24 
Therefore, these results are reported but are not likely to represent hypothesis-generating 25 
information and will not be discussed further. Pairwise interactions were not evaluated for all 26 
variables in the final models but instead evaluation for interaction was restricted to variables 27 
 30 
deemed to have a relevant biological interaction (sex and neuter); these variables were 1 
combined into one meta-variable to account for interrelatedness.  2 
 3 
Conclusions 4 
This study identifies breed associations with osteosarcoma risk in terms of both predisposition 5 
and protection. These results can inform breed health reforms, especially in breeds such as 6 
the Rottweiler, Rhodesian Ridgeback and the Great Dane which we have shown to be highly 7 
at risk. Other breed-associated variables (such as chondrodystrophy) were associated with 8 
protection from osteosarcoma. These findings could be used to identify protection-associated 9 
genetic variants for osteosarcoma, for example by identifying variants that are inherited in 10 
linkage with chondrodystrophic traits. The findings of this study will also inform research into 11 
human osteosarcoma, in which tumour genetics, risk factors including long bone length and 12 
body mass, and a clinical presentation involving early metastatic spread have all been shown 13 
to parallel canine disease. In summary, the current study generates hypotheses for further 14 
work interrogating the genetic and non-genetic risk factors for osteosarcoma, with the aim of 15 
informing novel diagnostics and therapeutics for osteosarcoma in both humans and dogs. 16 
 17 
Methods 18 
Data Sources  19 
The study population comprised 1756 osteosarcoma cases and 905,211 non-cases. Cases 20 
included all dogs with osteosarcoma in a database of biopsies submitted to VPG Histology 21 
(Bristol, UK) between January 2008 and January 2020 inclusive (23-25). Clinical and 22 
demographic information was supplied by the submitting veterinary practice and included an 23 
anonymised animal identifier along with breed, date of birth, sex/ neuter status and free-form 24 
pathological notes. Additional data fields were completed by a VPG histopathologist to provide 25 
the histopathological report, including osteosarcoma diagnosis, date sample received and 26 
date of final report. Cases were identified by the presence of the term “osteosarcoma” in the 27 
 31 
histopathological report. Reports were then reviewed to confirm that histopathological 1 
description reached a final diagnosis of osteosarcoma.  2 
 3 
The control population included all available dogs under primary veterinary care at clinics 4 
participating in the VetCompass programme during 2016, after excluding any dogs with 5 
osteosarcoma diagnosis recorded by the veterinarian in the clinical notes. VetCompass 6 
collates de-identified electronic patient record data from primary-care veterinary practices in 7 
the UK for epidemiological research (24, 25). Dogs with either a) at least one electronic patient 8 
record during 2016 or b) at least one electronic patient record during both 2015 and 2017 were 9 
included (72). Data fields used in the current study included a unique animal identifier along 10 
with species, breed, date of birth, sex/neuter status, and body mass, and also free-form text 11 
clinical notes, summary diagnosis terms and treatment with relevant dates (24, 25).  12 
Osteosarcoma cases were removed from the overall VetCompass population of dogs using 13 
search terms in the clinical notes (osteos*, OSA) to identify candidate cases that were then 14 
manually verified to check that an osteosarcoma diagnosis was recorded by the attending 15 
veterinarian (36). As cases were not chosen directly from the VetCompass control population, 16 
the incidence of osteosarcoma could not be determined in this study. However, as the control 17 
population was selected to represent the wider population of UK dogs that are registered for 18 
veterinary care, and therefore to represent the demography of dogs from which cases were 19 
sampled, the study design did permit exploration of the demographic risk factors associated 20 
with osteosarcoma risk and protection (35, 37, 62).  21 
  22 
Study Design  23 
A retrospective, case-control study design was used for risk factor analysis, comparing the 24 
VPG osteosarcoma cases and the VetCompass controls (62, 73). Before commencing the 25 
study, a power calculation was conducted based on published works. It was determined that 26 
a study with 1756 cases and 905,211 controls would give >99.99% power to detect differences 27 
in the odds of osteosarcoma between the Rottweiler (reported to be the most predisposed 28 
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breed in previous studies) and crossbreds ((74) with methodology from (75) table 6.3). This 1 
calculation was based on a previously reported osteosarcoma prevalence of 0.03% amongst 2 
crossbreds and 1.14% amongst Rottweilers, with Rottweilers comprising 1.17% of UK dogs 3 
(76, 77). 4 
 5 
Breed descriptive information recorded in the original VPG and VetCompass datasets was 6 
cleaned and mapped to a VetCompass breed list derived and extended from the VeNom 7 
Coding breed list (72). A purebred status variable categorised all dogs of recognisable breed 8 
as ‘purebred’, including designer crossbreeds with less than two breeds in the cross and with 9 
more than 1000 dogs of that designer breed in the VetCompass dataset. All remaining dogs 10 
with breed information, including the remaining designer crosses were categorised as 11 
‘crossbred’ (78). A full list of breed categories derived from the VeNom code is supplied in 12 
supplementary table S3. A separate breed variable included comprised the individual breed 13 
names of dogs listed as ‘purebred’ in the purebred status variable, if the breed was 14 
represented by over 1000 dogs in the overall study population and by ≥ 4 osteosarcoma cases. 15 
All remaining purebreds were grouped into the “other purebred” category under the breed 16 
variable. All dogs in the crossbred category of the purebred status variable were listed as 17 
‘crossbred’ under the breed variable.  18 
Breeds were further characterised by: skull-shape (dolichocephalic, mesocephalic, 19 
brachycephalic, unrecorded); spaniel-status (spaniel, non-spaniel, unrecorded) and 20 
dachshund-status (dachshund, non-dachshund, unrecorded) for analysis. A 21 
chondrodystrophic variable categorised pure-bred dogs as chondrodystrophic where there 22 
was published evidence that the allele encoding an autosomal dominant FGF4 mutation for 23 
chondrodystrophy located on chromosome 12 was fixed in the breed population (27-29). A 24 
table of breeds included in these lists are provided in supplementary Table S4. Where breeds 25 
could not be classified owing to a lack of published information, they were denoted as 26 
unrecorded. A Kennel Club breed group variable classified breeds recognised by the UK 27 
Kennel Club (KC) into their relevant breed groups (Gundog, Hound, Pastoral, Terrier, Toy, 28 
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Utility and Working) and all remaining types were classified as non-Kennel Club recognised 1 
(79). Toy breeds were used as the base for KC breed group analysis since they possess the 2 
smallest body mass of all groups, facilitating assessment of breed and confirmation related 3 
hypotheses. 4 
 5 
Neuter status was defined by the final available electronic patient record value in each dataset. 6 
Sex and neuter were combined into one variable after showing high collinearity during 7 
modelling (51). Adult body mass was not available for VPG histology cases. Therefore, body 8 
mass was imputed for the VPG histology dataset based on VetCompass standard weights for 9 
breed/sex combinations. These standards were calculated as the mean of all body mass (kg) 10 
values recorded for all dogs older than 18 months within each breed/sex combination in VC, 11 
where 100 dogs of that breed were available. Body mass (kg) values for both datasets were 12 
then categorised: < 10.0, 10.0 to < 20.0, 20.0 to < 30.0, 30.0 to < 40.0 and ≥ 40.0. Age was 13 
defined at the date of histological submission for the VPG cases (24, 72, 80)  and on 14 
December 31, 2016 for the VetCompass non-cases. Age (years) was categorised as: ≤ 1.0, 15 
1.0 to < 3.0, 3.0 to < 6.0, 6.0 to < 9.0, 9.0 to < 12.0 and ≥ 12.0. Where mean breed bodyweight 16 
was plotted against osteosarcoma risk, if multiple VeNom breed terms were included in the 17 
Final Breed Term used to determine risk (e.g. ‘Akita – unspecified’ includes dogs recorded as 18 
Akita, American Akita and Japanese Akita, see supplementary data S2) then, where available, 19 
the mean weights of males and females of all the breeds included was utilised. 20 
 21 
Statistical Analysis 22 
Following internal validity checking and data cleaning in Excel (Microsoft Office Excel 2013, 23 
Microsoft Corp.), data were cleaned in Rstudio™ using the following packages: plyr, dplyr, 24 
data.table, tidyR, and stringr (81-84). Binary logistic regression modelling was executed using 25 
the glm-logit function in the R-stats package to determine univariable associations between 26 
risk factors (purebred-status, breed, Kennel Club breed group, body mass, age, sex/neuter, 27 
dachshund-status, spaniel-status, chondrodystrophy-status and skull-shape) and 28 
 34 
osteosarcoma (85). Univariable evaluation showed that the median age of cases (8.50 years, 1 
IQR 6.58-10.50) was higher than non-cases (4.40 years, IQR 1.87-8.08) (Mann-Whitney test 2 
p < 0.001). The median adult body mass amongst cases (29.78kg, IQR 18.51-35.74) was 3 
higher than non-cases (16.29kg, IQR 8.95-21.95) (Mann-Whitney test, p < 0.001) (Table 1).  4 
Because breed was a factor of primary interest for the study, variables derived from the breed 5 
information were tested for collinearity using a VIF score available in the caret package (51, 6 
86-89). Variables that were highly collinear with breed (purebred, Kennel Club breed group, 7 
body mass, dachshund-status, spaniel-status, chondrodystrophic, skull-shape) were excluded 8 
from initial breed multivariable modelling. VIF scores for the breed multivariable model are 9 
included in supplementary Table S5 to show that no significant collinearity remained after 10 
taking this approach. Instead, each of these variables individually replaced the breed variable 11 
in the final breed-focused model to evaluate their effects after taking account of the other 12 
variables. Risk factors with liberal associations in univariable modelling (P < 0.02) were taken 13 
forward for multivariable evaluation (90). The area under the ROC curve was calculated using 14 
the pROC package and used to evaluate the quality of the model fit and discrimination (non-15 
random effect model) (90). No observations were dropped from the model during fitting, 16 
meaning that confidence intervals and p-values were generated for breeds with no cases, 17 
although these are not reported. Statistical significance was set at P < 0.05 (91). A global P-18 
value for each variable was calculated for the univariable models using ANOVA and for 19 
multivariable models using the likelihood ratio test available in the package lmtest (92). The R 20 
script used to execute the above analyses is available at 21 
https://github.com/ge8793/Osteosarcoma_Public_Data .  22 
 23 
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Table 1  
  
Variable P-Value for 
Variable  




OR 95% CI P-value for 
Category 
Purebred Status <0.001 Crossbred 300 (17.1) 197549 (21.8) Base 
    




Purebred status unrecorded 27 ( 1.5) 4061 ( 0.4) 4.38 2.95 - 6.5 <0.001 
Breed < 0.001 Crossbred 300 (17.1) 197549 (21.8) Base 
  
  



























































































American Bulldog 8 (0.5) 3225 (0.4) 1.63 0.81 - 3.3 0.171 
  


















































































Shar-Pei NA (NA) 3647 (0.4) 
   
  
Cavachon NA (NA) 3535 (0.4) 
   
  
Maltese NA (NA) 3248 (0.4) 
   
  
Cavapoo NA (NA) 4035 (0.4) 
   
  
Cockapoo NA (NA) 18260 (2.0) 
   
 54 
  
King Charles Spaniel NA (NA) 2813 (0.3) 
   
  
Sprocker NA (NA) 3338 (0.4) 
   
  
Miniature Poodle NA (NA) 2415 (0.3) 
   
  
Boston Terrier NA (NA) 1799 (0.2) 
   
  
Chow Chow NA (NA) 1002 (0.1) 
   
  
Dachshund (Unspecified) NA (NA) 1692 (0.2) 
   
  
Goldendoodle NA (NA) 1128 (0.1) 
   
  
Jackapoo NA (NA) 1362 (0.2) 
   
  
Jug NA (NA) 1967 (0.2) 
   
  
Miniature Yorkshire Terrier NA (NA) 1560 (0.2) 
   
  
Puggle NA (NA) 1173 (0.1) 
   
  
Standard Dachshund NA (NA) 1133 (0.1) 
   
KC Breed Group <0.001 Toy 26 (1.5) 131897 (14.6) Base 
  
  





















Utility 46 (2.6) 102627 (11.3) 2.27 1.41 - 
3.68 
0.001 
Body mass (kg) <0.001 <10 89 (5.1) 213321 (23.6) Base 
  
  

















Body mass Unrecorded 87 (5.0) 310462 (34.3) 0.67 0.50 - 
0.90 
0.008 
Age (y) <0.001 <3 101 (5.8) 329270 (36.4) Base 
  
  
















Age Unrecorded 85 (4.8) 12423 (1.4) 22.31 16.71 - 
29.78 
<0.001 
Sex/Neuter Status <0.001 Female Entire 41 (2.3) 233772 (25.8) Base 
  
  




















<0.001 Non-Dachshund-type 1426 (81.2) 696999 (77.0) Base 
  
  




Dachshund Status Unrecorded 327 (18.6) 197924 (21.9) 0.81 0.72 - 
0.91 
<0.001 
Spaniel Status <0.001 Non-Spaniel-type 1360 (77.4) 630349 (69.6) Base 
  
  











Non-Chondrodystriphic 1165 (66.3) 290490 (32.1) Base 
  
  




Chondrodystrophy Unrecorded 426 (24.3) 282863 (31.2) 0.38 0.34 - 
0.42 
<0.001 
Skull Shape  <0.001 Mesocephalic 982 (55.9) 452296 (50.0) Base 
  
  














 Table 2A  
Variable Variable P-value Category OR 95% CI Category P-
value 
Breed <0.001 Crossbred Base 
  
  
Rottweiler 13.30 10.55 - 16.75 <0.001 
  
Rhodesian Ridgeback 11.31 7.37 - 17.35 <0.001 
  
Great Dane 10.03 5.81 - 17.32 <0.001 
  
Mastiff (Unspecified) 9.09 6.06 - 13.63 <0.001 
  
German Pointer 8.84 5.43 - 14.41 <0.001 
  
Pinscher (Unspecified) 7.19 4.65 - 11.12 <0.001 
  
Greyhound (Unspecified) 6.98 5.46 - 8.93 <0.001 
  
Lurcher 4.94 3.57 - 6.83 <0.001 
  
Collie (Unspecified) 3.74 1.99 - 7.03 <0.001 
  
Golden Retriever 3.70 2.77 - 4.94 <0.001 
  
Akita (Unspecified) 2.92 1.32 - 6.47 0.008 
  
American Bulldog 2.67 1.28 - 5.59 0.009 
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Labrador Retriever 2.64 2.22 - 3.15 <0.001 
  
Poodle (Unspecified) 2.48 0.87 - 7.00 0.088 
  
Boxer 2.23 1.55 - 3.22 <0.001 
  
Standard Poodle 2.23 0.87 - 5.72 0.096 
  
Weimaraner 2.03 1.06 - 3.90 0.034 
  
German Shepherd Dog 1.96 1.47 - 2.62 <0.001 
  
Dogue de Bordeaux 1.95 0.88 - 4.33 0.100 
  
Fox Terrier 1.75 0.64 - 4.74 0.274 
  
Labradoodle 1.62 0.97 - 2.72 0.066 
  
Hungarian Vizsla 1.52 0.58 - 3.99 0.395 
  
Scottish Terrier 1.33 0.51 - 3.45 0.563 
  
Cairn Terrier 1.24 0.55 - 2.84 0.603 
  
Alaskan Malamute 1.23 0.44 - 3.47 0.695 
  
Tibetan Terrier 1.22 0.47 - 3.12 0.684 
  
Bulldog (Unspecified) 1.17 0.42 - 3.27 0.758 
  
Whippet 1.10 0.50 - 2.40 0.814 
  
Dalmatian 1.00 0.40 - 2.52 0.993 
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English Springer Spaniel 0.89 0.60 - 1.31 0.541 
  
Border Collie 0.82 0.55 - 1.22 0.324 
  
Other Purebred 0.78 0.65 - 0.93 0.006 
  
Staffordshire Bull Terrier 0.74 0.56 - 0.98 0.033 
  
Beagle 0.66 0.29 - 1.51 0.328 
  
Breed not recorded 0.52 0.34 - 0.80 0.003 
  
Cocker Spaniel 0.51 0.34 - 0.78 0.002 
  
West Highland White Terrier 0.50 0.32 - 0.80 0.004 
  
Husky 0.43 0.16 - 1.17 0.097 
  
Jack Russell Terrier 0.38 0.26 - 0.54 <0.001 
  
Border Terrier 0.35 0.16 - 0.81 0.013 
  
Bichon Frise 0.30 0.14 - 0.64 0.002 
  
French Bulldog 0.30 0.11 - 0.83 0.020 
  
Cavalier King Charles 
Spaniel 
0.21 0.10 - 0.46 <0.001 
  


























































Female Neutered 7.95 5.78 - 10.94 <0.001 
  
Male Entire 1.17 0.79 - 1.74 0.441 
  
Male Neutered 9.39 6.83 - 12.91 <0.001 
  
Sex/Neuter unrecorded 1188.3 855.25 - 
1651.04 
<0.001 
Age (Y)  <0.001 <3 Base 
  
  
3 to <6 3.64 2.82 - 4.70 <0.001 
  
6 to <9 13.30 10.54 - 16.79 <0.001 
  
9 to <12 18.44 14.59 - 23.30 <0.001 
  
>12 9.40 7.23 - 12.23 <0.001 
  





Variable  Variable P-value Category OR 95% CI Category P-
value 




Purebred 1.35 1.18 - 1.54 <0.001 
  
Unrecorded 0.52 0.33 - 0.79 0.003 
KC Breed Group <0.001 Toy Base 
  
  
Gundog 14.48 9.72 - 21.58 <0.001 
  
Hound 21.54 14.14 - 32.81 <0.001 
  
Not_KC_Recognised 7.10 4.75 - 10.59 <0.001 
  
Pastoral 11.22 7.33 - 17.15 <0.001 
  
Terrier 3.87 2.54 - 5.90 <0.001 
  
Unrecorded 27.39 18.24 - 41.13 <0.001 
  
Utility 2.42 1.49 - 3.94 <0.001 
Body mass (kg)  <0.001 <10 Base 
  
  
10-19.9 5.91 4.66 - 7.50 <0.001 
  
20-29.9 7.31 5.75 - 9.30 <0.001 
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30-39.9 15.82 12.49 - 20.05 <0.001 
  
>40 18.07 13.87 - 23.53 <0.001 
  
Unrecorded 0.15 0.10 - 0.22 <0.001 
Dachshund status <0.001 Non-Dachshund type Base 
  
  
Dachshund type 0.15 0.05 - 0.46 0.001 
  
Unrecorded 0.70 0.61 - 0.79 <0.001 
Spaniel status <0.001 Non-Spaniel type Base 
  
  
Spaniel type 0.37 0.29 - 0.47 <0.001 
  








Chondrodystrophic 0.13 0.11 - 0.16 <0.001 
  
Unrecorded 0.40 0.36 - 0.45 <0.001 
Skull shape <0.001 Mesocephalic Base 
  
  
Brachycephalic 0.39 0.32 - 0.48 <0.001 
  
Dolichocephalic 1.92 1.68 - 2.19 <0.001 
 
 
